10-11 October 2024, Stockholm Sweden
Conference programme NMCC 2024
| THURSDAY 10 OCTOBER 2024 | |||
|---|---|---|---|
| 09:00-09:30 | Welcome words | Lars-Olof Wahlund (Local representative of NIDD) Miia Kivipelto (Theme Aging at Karolinska University Hospital) Daniel Ferreira (Center for Alzheimer Research at Karolinska Institutet) | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 09:30-11:00 | Session 1 - Alzheimer´s disease | Chair: Peter Høgh "Emerging treatments in Alzheimer´s disease." Kristian Steen Frederiksen (Denmark) "Real-world validation of a blood test for Alzheimer’s disease in primary and secondary care." Sebastian Palmqvist (Sweden) "Implementation of Anti-Amyloid Drug Treatment at Memory Clinics." Anne Koivisto (Finland) "Alzheimer’s disease – could it be prevented?" Geir Selbæk (Norway) | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 11:00-12:30 | Lunch & Poster viewing | ||
| 11:15-12:20 | Lunch symposium on the latest results on Souvenaid | Nutricia SouvenaidSymposium program here | Venue: Wretling, Widerströmska huset |
| 12:30-14:00 | Session 2 - Related disorders | Chair: Daniel Ferreira "Frontotemporal dementia: diagnosis at cognitive clinics and upcoming clinical trials." Caroline Graff (Sweden) "Vascular cognitive impairment: diagnosis/selection of patients for implementation of treatments at cognitive clinics." Susanna Melkas (Finland) "DLB: diagnosis/selection of patients for implementation of treatments at cognitive clinics." Elisabet Londos (Sweden) ”Normal pressure hydrocephalus as a memory disorder and a window for living human brain.” Ville Leinonen (Finland) | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 14:00-15:00 | Coffee/Tea & Poster viewing | ||
| 15:00-16:30 | Session 3 -Registration of DMTs in Nordic countries | Chair: Anne-Brita Knapskog "Why should we register real world data on DMT?– international initiatives." Jon Snaedal (Iceland) "The Nordic Network in Dementia Diagnostics (NIDD): a platform to collect data on dementia biomarkers and treatment outcomes." Knut Engedal (Norway) "Use of quality registries to follow-up new DMT´s- the example of SveDem." Maria Eriksdotter (Sweden) "ARIA as an adverse event for DMTs in AD - proposed practical guidelines." Tobias Granberg (Sweden) | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 15:00-16:30 Parallel session | Nursing Group | Chair: Susanne Kristiansen "Brief Assessment of Impaired Cognition (BASIC) – a new case-finding instrument for cognitive impairment and dementia." Niels Kasper Jørgensen(Denmark) "Living with dementia at home: Receiving and adapting to a specialised day programme." Margrét Guðnadóttir (Iceland) "Prevention of Frail Elderly Syndrome and Individual Lifestyle Management." Maria Pentti (Finland) "Living in risk of Alzheimer´s disease." Susanne Kristiansen (Denmark) | Venue: Rehabsalen, Norrbackahuset, Karolinska University Hospital |
| 15:00-16:30 Parallel session | Psychology Group | Chair: Anne Koivisto "An RCT evaluation of a novel Psychological Intervention tailored for Patients with early Cognitive Impairment (PIPCI)." Urban Ekman (Sweden) "The Link between Hearing Loss and Dementia." Rebecca Hendel (Denmark) "Cognitive assessment in the context of traditional and novel biomarkers." Göran Hagman and Zuzana Istvanfyova (Sweden) "Determinants and early identification of cognitive and neuropsychiatric symptoms in cerebral small vessel disease." Hanna Jokinen (Finland) | Venue: Marie Åsberg Karolinska University Hospital (BioClinicum) |
| 16:45-17:45 | Industry sponsored symposium | Eli Lilly More information here | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 19:00 | Conference dinner | Haga Bottega | |
| FRIDAY 11 OCTOBER 2024 | |||
|---|---|---|---|
| 09:00-10:30 | Session 4 - Neuropsychiatric symptoms | Chair: Helga Eyjolfsdottir "Introduction on neuropsychiatric symptoms and challenges - National guidelines in Finland." Risto Vataja (Finland) "Psychosocial treatment and communication with people with dementia and frontotemporal symptoms - Current best practice." Marit Mjørud (Norway) "Pharmacotherapy of neuropsychiatric symptoms in early stages of neurocognitive disorders." Simona Sacuiu (Sweden) "Neuropsychiatric symptoms in dementia, best practice and drug pipeline." Helga Eyjólfsdóttir (Iceland) | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 10:30-11:30 | Coffee/Tea & Poster viewing | ||
| 11:30-11:55 | Closing Key Lecture | Chair: Miia Kivipelto "Towards diagnosis ánd treatment of AD: how memory clinics may evolve in the coming years." Wiesje van der Flier (Amsterdam UMC, The Netherlands) | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 11:55-12:00 | Concluding remarks | Miia Kivipelto Lars-Olof Wahlund Daniel Ferreira | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
| 12:00-14:00 | Industry sponsored symposium Including Lunch | Eisai & BioArctic This symposium is intended only for Nordic Healthcare Professionals participating the Nordic Memory Clinic Conference – NMCC 2024 Improving patient management and defining meaningful benefits in Alzheimer’s disease. 12:00-12:35 Welcome and introduction Prof. Miia Kivipelto MD, PhD Lunch will be served 12:35-12:50 A new era in the management and diagnosis of patients with Alzheimer’s disease Assoc. Prof. Kristian Steen Frederiksen MD, PhD 12:50-13:05 Understanding meaningful benefits with Alzheimer’s Disease treatments Assoc. Prof. Sebastian Palmqvist MD, PhD 13:05-13:20 Meaningful benefits in Alzheimer’s Disease – What does this mean to patients, caregivers and health care system? Prof. Miia Kivipelto MD, PhD 13:20-13:50 Panel discussion and Q&A Assoc. Prof. Kristian Steen Frederiksen MD, PhD Assoc. Prof. Sebastian Palmqvist MD, PhD Prof. Miia Kivipelto MD, PhD 13:50-14:00 Closing remarks Prof. Miia Kivipelto MD, PhD | Venue: Sune Bergström, Karolinska University Hospital (BioClinicum) |
